Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>The Clorox Company reported a robust first quarter for the fiscal year 2025, showcasing a strong comeback from previous challenges and demonstrating significant advancements in both market share restoration and gross margin expansion.</li><li>Linda Rendle, the CEO, emphasized the recovery from the August 2023 cyber attack, which had impacted supply and distribution.</li><li>The company reported that it has not only restored but also expanded its market share across multiple categories, attributing its success to strategic investments in marketing and innovation.</li></ul>

The Clorox Company reported a robust first quarter for the fiscal year 2025, showcasing a strong comeback from previous challenges and demonstrating significant advancements in both market share restoration and gross margin expansion.Linda Rendle, the CEO, emphasized the recovery from the August 2023 cyber attack, which had impacted supply and distribution.The company reported that it has not only restored but also expanded its market share across multiple categories, attributing its success to strategic investments in marketing and innovation.

The Clorox Company: Its Enhanced Focus On High Margin Products As A Vital Tool For Growth! - Major Drivers

<ul><li>The Clorox Company presented its fiscal year 2024 fourth-quarter earnings with a moderate sense of optimism and caution, reflecting a period of recovery and strategic realignment.</li><li>In a context of considerable operational challenges, including a notable cyberattack which the company has recovered from, Clorox has managed to end the fiscal year on a stable note, achieving flat organic sales year-over-year, marked by a robust recovery in subsequent quarters following an 18% decline in the first quarter due to the cyber incident.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

The Clorox Company presented its fiscal year 2024 fourth-quarter earnings with a moderate sense of optimism and caution, reflecting a period of recovery and strategic realignment.In a context of considerable operational challenges, including a notable cyberattack which the company has recovered from, Clorox has managed to end the fiscal year on a stable note, achieving flat organic sales year-over-year, marked by a robust recovery in subsequent quarters following an 18% decline in the first quarter due to the cyber incident.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

The Clorox Company: A Dive Into Its Market Positioning

<ul><li>The Clorox Company's third-quarter financial results suggest a continuing recovery from the August cyberattack that affected its operations.</li><li>Despite lower sales and significant investments in its brands, the company's adjusted earnings per share exceeded its own expectations in the said quarter.</li><li>Adjusting for the effects of the cyberattack, the company reported that Q3 sales performance was, for the most part, in line with the management's expectations.</li></ul>

The Clorox Company's third-quarter financial results suggest a continuing recovery from the August cyberattack that affected its operations.Despite lower sales and significant investments in its brands, the company's adjusted earnings per share exceeded its own expectations in the said quarter.Adjusting for the effects of the cyberattack, the company reported that Q3 sales performance was, for the most part, in line with the management's expectations.

The Clorox Company: A Story Of Innovation-Led Growth

Podcast hosted by Hedgeye CEO Keith McCullough, Real Conversations

Real Conversations

Podcast hosted by Hedgeye CEO Keith McCullough

Hedgeye is an investment research and financial media company founded in 2008. Our core principles are transparency, accountability and trust. Hedgeye’s Real Conversations series, hosted by CEO Keith McCullough, brings together the brightest minds in the business to cut through the noise and discuss the financial market moves that actually matter.LEGALThe opinions expressed in Hedgeye Real Conversations are those of the individual speaking and not of Hedgeye, and should not be construed as specific investment advice. Hedgeye® is a registered trademark. All Hedegye Real Conversations are the intellectual property of Hedgeye. All rights reserved.

Cross Asset Strategy

<ul><li>Russell was down almost a full percent last week, but consumer staples, MLPS, and shipping performed well</li><li>Domino's reported slightly lower earnings and showed signs of global headwinds, momentum slowing</li><li>China looks like a good long bias opportunity for the second half of 2024, while consumer staples are poorly positioned for reaccelerating inflation</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.</em></p>

Russell was down almost a full percent last week, but consumer staples, MLPS, and shipping performed wellDomino's reported slightly lower earnings and showed signs of global headwinds, momentum slowingChina looks like a good long bias opportunity for the second half of 2024, while consumer staples are poorly positioned for reaccelerating inflationThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

<ul><li>The Clorox Company delivered second-quarter financial results for 2024 that exceeded expectations, driven largely by a strong recovery from a cyber attack that occurred in August.</li><li>The company preserved its strong brand superiority by advancing its strategies to drive top line growth and rebuild margins, as well as actively managing currency headwinds in Argentina.</li><li>Retailer inventories are being refreshed more quickly than anticipated, which is aiding the restoration of distribution and improvement of market shares.</li></ul>

The Clorox Company delivered second-quarter financial results for 2024 that exceeded expectations, driven largely by a strong recovery from a cyber attack that occurred in August.The company preserved its strong brand superiority by advancing its strategies to drive top line growth and rebuild margins, as well as actively managing currency headwinds in Argentina.Retailer inventories are being refreshed more quickly than anticipated, which is aiding the restoration of distribution and improvement of market shares.

The Clorox Company: A Genius Strategy to Crush Digital Transformation and Improve Sales! - Major Drivers

United States

The Clorox Company produces and markets non-durable consumer products sold primarily through grocery and other retail stores.  The Company's principal products include household cleaning and bleach products, charcoal, cat litter, automotive care products, dressings, and trash bags.  Clorox markets its products in the United States and other countries around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Clorox Company (CLX US)

The Clorox Company: Its Enhanced Focus On High Margin Products As A Vital Tool For Growth! - Major Drivers

The Clorox Company reported a robust first quarter for the fiscal year 2025, showcasing a strong comeback from previous challenges and...

Baptista Research

The Clorox Company: A Dive Into Its Market Positioning

The Clorox Company presented its fiscal year 2024 fourth-quarter earnings with a moderate sense of optimism and caution, reflecting a period of...

Baptista Research

The Clorox Company: A Story Of Innovation-Led Growth

The Clorox Company's third-quarter financial results suggest a continuing recovery from the August cyberattack that affected its...

Baptista Research

The Call @ Hedgeye | February 26, 2024

Last week saw a mixed market with Russell down almost 1%, consumer staples and MLPs performing well, Howard's cannabis MSOs showing strength,...

Real Conversations

The Clorox Company: A Genius Strategy to Crush Digital Transformation and Improve Sales! - Major Drivers

The Clorox Company delivered second-quarter financial results for 2024 that exceeded expectations, driven largely by a strong recovery from a...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)